Inventor · disambiguated record
Ashley Anne Katana
Also filed as: KATANA ASHLEY · KATANA ASHLEY A · KATANA ASHLEY ANNE
23 granted patents·11 pending applications·270 citations·filing 2011–2025
96Inventor score
Top patents by PatentIndex Score
34 records- 0198US11078208B1HIV inhibitor compoundsGILEAD SCIENCES INC·Filed 2020·Granted Aug 3, 2021·13 cites·23 claims
- 0298US10294234B2HIV inhibitor compoundsGILEAD SCIENCES INC·Filed 2018·Granted May 21, 2019·43 cites·26 claims
- 0398US8575135B2Antiviral compoundsGILEAD SCIENCES INC·Filed 2013·Granted Nov 5, 2013·42 cites·7 claims
- 0497US9221833B2Antiviral compoundsGILEAD PHARMASSET LLC·Filed 2015·Granted Dec 29, 2015·20 cites·1 claims
- 0597US8921341B2Antiviral compoundsGILEAD PHARMASSET LLC·Filed 2013·Granted Dec 30, 2014·31 cites·7 claims
- 0696US9051340B2Antiviral compoundsGILEAD PHARMASSET LLC·Filed 2014·Granted Jun 9, 2015·20 cites·1 claims
- 0796US8940718B2Antiviral compoundsGILEAD SCIENCES INC·Filed 2012·Granted Jan 27, 2015·26 cites·28 claims
- 0895US10752636B2HIV inhibitor compoundsGILEAD SCIENCES INC·Filed 2019·Granted Aug 25, 2020·7 cites·58 claims
- 0994US12084455B2HIV inhibitor compoundsGILEAD SCIENCES INC·Filed 2021·Granted Sep 10, 2024·2 cites·18 claims
- 1092US9868745B2Antiviral compoundsGILEAD PHARMASSET LLC·Filed 2014·Granted Jan 16, 2018·8 cites·9 claims
- 1192US9296782B2Inhibitors of hepatitis C virusGILEAD SCIENCES INC·Filed 2013·Granted Mar 29, 2016·13 cites·16 claims
- 1291US9376441B2Substituted pyrrolidines as SYK inhibitorsGILEAD SCIENCES INC·Filed 2014·Granted Jun 28, 2016·17 cites·20 claims
- 1390US12479853B2HIV inhibitor compoundsGILEAD SCIENCES INC·Filed 2024·Granted Nov 25, 2025·0 cites·5 claims
- 1490US11987577B2Therapeutic compounds and methodsACTIO BIOSCIENCES INC·Filed 2023·Granted May 21, 2024·1 cites·20 claims
- 1589US10807990B2Antiviral compoundsGILEAD PHARMASSET LLC·Filed 2018·Granted Oct 20, 2020·1 cites·2 claims
- 1689US9156823B2Antiviral compoundsBACON ELIZABETH M·Filed 2011·Granted Oct 13, 2015·17 cites·16 claims
- 1786US9809600B2Antiviral compoundsGILEAD PHARMASSET LLC·Filed 2016·Granted Nov 7, 2017·2 cites·2 claims
- 1883US12391683B2Therapeutic compounds and methodsACTIO BIOSCIENCES INC·Filed 2024·Granted Aug 19, 2025·0 cites·20 claims
- 1983US10005774B2Syk inhibitorsGILEAD SCIENCES INC·Filed 2016·Granted Jun 26, 2018·4 cites·9 claims
- 2082US9655944B2Inhibitors of hepatitis C virusGILEAD SCIENCES INC·Filed 2016·Granted May 23, 2017·2 cites·2 claims
- 2180US10335409B2Inhibitors of hepatitis C virusGILEAD PHARMASSET LLC·Filed 2018·Granted Jul 2, 2019·1 cites·2 claims
- 2277US2025333403A1Therapeutic compounds and methodsACTIO BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 2376US2021053981A1Antiviral compoundsGILEAD PHARMASSET LLC·Filed 2020·Application pending·0 cites
- 2473US10603318B2Inhibitors of hepatitis C virusGILEAD PHARMASSET LLC·Filed 2019·Granted Mar 31, 2020·0 cites·2 claims
- 2572US2020071337A1Antiviral compoundsGILEAD PHARMASSET LLC·Filed 2019·Application pending·0 cites
- 2669US2018186806A1Antiviral compoundsGILEAD PHARMASSET LLC·Filed 2017·Application pending·0 cites
- 2769US2020123132A1Antiviral compoundsGILEAD PHARMASSET LLC·Filed 2019·Application pending·0 cites
- 2868US2018244683A1Antiviral compoundsGILEAD PHARMASSET LLC·Filed 2017·Application pending·0 cites
- 2963US2016083394A1Antiviral compoundsGILEAD PHARMASSET LLC·Filed 2015·Application pending·0 cites
- 3061US2017290827A1Inhibitors of hepatitis c virusGILEAD SCIENCES INC·Filed 2017·Application pending·0 cites
- 3158US2016130300A1Inhibitors of hepatitis c virusGILEAD SCIENCES INC·Filed 2016·Application pending·0 cites
- 3255US10344019B2Antiviral compoundsGILEAD PHARMASSET LLC·Filed 2015·Granted Jul 9, 2019·0 cites·7 claims
- 3355US2025313548A1Heterocyclic compounds useful as kcnt1 inhibitorsACTIO BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 3439US2017342068A1Compounds for the treatment of hepatitis b virus infectionGILEAD SCIENCES INC·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →